Harvard Bioscience Balance Sheet - Quarterly (NASDAQ:HBIO)

Add to My Stocks
$5 $0.15 (3.09%) HBIO stock closing price Feb 22, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Harvard Bioscience balance sheet. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Harvard Bioscience stock analysis, and provides insights into the firm's financial performance. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Harvard Bioscience had a long term debt of $9.67M at the end of 2017 Q3. To understand the debt servicing capacity of the company, one needs to look at Harvard Bioscience operating cash flow and Harvard Bioscience revenue also. Harvard Bioscience debt to equity ratio is 0.16.

View and download Harvard Bioscience quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Cash5.83M4.72M4.59M5.59M5.34M3.63M4.17M6.74M6.09M
Marketable Securities---------
Receivables20.18M20.74M20.24M19.92M19.57M20.97M22.35M21.42M20.66M
Inventory21.38M20.37M20.28M19.95M21.23M22.2M22.21M22.34M23.01M
Raw Materials10.76M10.3M9.69M9.79M10.83M11.03M10.69M10.49M11.89M
Work In Progress-----1.08M1.13M--
Finished Goods9.73M9.3M9.68M9.34M9.46M10.09M10.39M10.95M10.16M
Notes Receivable---------
Other Current Assets--------2.56M
Total Current Assets
47.39M45.83M45.12M45.47M46.15M46.81M48.74M50.54M52.32M
Property Plant & Equipment20.65M20.06M19.34M18.9M21.98M22.06M22.15M21.92M21.57M
Accumulated Depreciation16.39M15.77M15.07M14.6M16.71M16.42M16.41M16.01M15.64M
Net Property Plant & Equipment
4.26M4.28M4.26M4.29M5.26M5.64M5.73M5.9M5.93M
Investment & Advances---------
Other Non-Current Assets---------
Deferred Charges1.27M1.23M1.17M1.15M--1.03M-11.04M
Intangibles57.62M57.37M56.68M56.71M59.71M60.57M62.23M62.45M63.9M
Deposits & Other Assets---------
Total Assets
110.67M108.85M107.39M107.76M112.17M114.08M117.88M120.21M133.55M
Notes Payable--------1.36M
Accounts Payable5.6M5.58M5.83M6.19M6.14M6.57M6.17M8.78M6.32M
Current Portion Long-Term Debt2.76M2.77M2.72M2.37M2.37M2.38M2.37M2.45M5M
Current Portion Capital Leases---------
Accrued Expenses4.69M3.86M4.42M4.77M4.71M4.19M5.85M4.31M4.05M
Income Taxes Payable-------2.24M-
Other Current Liabilities-1.01M1.07M1.26M1.2M1.68M1.49M1.62M1.65M
Total Current Liabilities
13.94M13.23M14.05M14.6M14.44M14.85M15.89M19.4M17.27M
Mortgages---------
Deferred Taxes/Income6.62M6.55M6.46M6.41M6.53M6.07M6.11M3.77M2.25M
Convertible Debt---------
Long-Term Debt9.67M10.41M10.93M11.37M12.66M13.77M14.77M16.45M15.15M
Non-Current Capital Leases---------
Other Long-Term Liabilities3.52M3.43M3.23M3.17M2.64M2.72M2.9M2.98M4.59M
Total Liabilities
33.77M33.64M34.68M35.56M36.28M37.42M39.68M42.61M39.26M
Minority Interest---------
Preferred Stock---------
Common Stock Net---------
Capital Surplus217.63M216.72M215.84M215.13M214.13M213.1M212.09M211.45M210.65M
Retained Earnings-117.96M-117.54M-117.16M-116.03M-114.71M-113.07M-112.35M-111.72M-94.58M
Treasury Stock10.66M10.66M10.66M10.66M10.66M10.66M10.66M10.66M10.66M
Other Liabilities-12.51M-13.71M-15.7M-16.65M-13.28M-13.11M-11.29M-11.88M-11.53M
Shareholders Equity76.9M75.21M72.71M72.19M75.89M76.66M78.19M77.59M94.28M
Total Liabilities & Shareholders Equity110.67M108.85M107.39M107.76M112.17M114.08M117.88M120.21M133.55M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Most investors just check the Harvard Bioscience stock price, and Harvard Bioscience historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Harvard Bioscience PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: HBIO total assets, which was at $110.67M for 2017 Q3 is a balance sheet item representing value of what Harvard Bioscience owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Harvard Bioscience is $33.77M. Shareholders equity comes under liabilities as it is money the company owes the holders of HBIO stock.

Harvard Bioscience Balance Sheet - Key Ratios

Current ratio
3.4
Debt to equity ratio
0.16
Asset turnover ratio
0.91
Receivables turnover
5.01
Price to book ratio
2.34